Showing results (941-950 of 31,337) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|April 17, 1998
Synthesis and evaluation of compounds that facilitate the gastrointestinal absorption of heparinA Leone-Bay, D R Paton, J Freeman, et al.Journal of Medicinal Chemistry|April 17, 1998
Pharmacophoric requirements for cannabinoid side chains: multiple bond and C1'-substituted delta 8-tetrahydrocannabinolsD P Papahatjis, T Kourouli, V Abadji, et al.Journal of Medicinal Chemistry|April 17, 1998
Simultaneous measurement of nineteen binding constants of peptides to vancomycin using affinity capillary electrophoresis-mass spectrometryY M Dunayevskiy, Y V Lyubarskaya, Y H Chu, et al.Journal of Medicinal Chemistry|May 9, 1998
Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocketM Yamamoto, H Tsujishita, N Hori, et al.Journal of Medicinal Chemistry|May 9, 1998
The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor function both in vitro and in vivoL M Gaster, F E Blaney, S Davies, et al.Journal of Medicinal Chemistry|May 9, 1998
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulatorsT A Grese, L D Pennington, J P Sluka, et al.Journal of Medicinal Chemistry|May 9, 1998
Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cellsD J Taatjes, D J Fenick, T H KochJournal of Medicinal Chemistry|May 9, 1998
Structure-activity studies on anticonvulsant sugar sulfamates related to topiramate. Enhanced potency with cyclic sulfate derivativesB E Maryanoff, M J Costanzo, S O Nortey, et al.Journal of Medicinal Chemistry|May 23, 1998
Structure-activity relationship of new growth inhibitors of Trypanosoma cruziG M Cinque, S H Szajnman, L Zhong, et al.Journal of Medicinal Chemistry|October 1, 1985
Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazolesP E Cross, R P Dickinson, M J Parry, et al.Pageof 3,134